ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

0QQ6 Roche Holding Ag

229.20
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Roche Holding Ag 0QQ6 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 229.20 09:00:00
개장가 저가 고가 종가 전일 종가
229.20
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202414:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales..
24/04/202414:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der..
19/04/202414:00UKREGFDA approves Roche’s Alecensa as the first adjuvant..
17/04/202415:00UKREGRoche’s subcutaneous OCREVUS one-year data demonstrates..
15/04/202414:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi..
11/04/202414:00UKREGRoche granted FDA Breakthrough Device Designation for blood..
27/03/202401:45UKREGRoche receives FDA approval for the first molecular test to..
12/03/202421:30UKREGRoche Annual General Meeting 2024
12/03/202421:30UKREGAssemblée générale 2024 de Roche
12/03/202421:30UKREGRoche Generalversammlung 2024
05/03/202421:30UKREGRoche and Alnylam report positive topline results from the..
26/02/202404:00UKREGNew England Journal of Medicine publishes Phase III data..
17/02/202401:24UKREGFDA approves Xolair as first and only medicine for children..
01/02/202415:03UKREGNew long-term data for Roche’s Vabysmo show sustained..
01/02/202415:00UKREG[Annonce événementielle au sens de l’art. 53 RC] Roche..
01/02/202415:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds..
01/02/202415:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft..
16/01/202415:00GLOBEEuropean Commission approves Roche’s Tecentriq SC, the EU's..
30/12/202306:30GLOBERoche enters into a definitive agreement to acquire..
19/12/202323:40GLOBEFDA grants priority review to Xolair (omalizumab) for..
15/12/202315:15GLOBERoche named among top three most sustainable healthcare..
11/12/202315:00GLOBENew data for Roche’s Columvi and Lunsumio presented at ASH..
10/12/202301:30GLOBENew data reinforce the benefit of early preventative..
09/12/202301:50GLOBERoche's Kadcyla is the first targeted therapy to show..
09/12/202301:45GLOBERoche’s inavolisib combination reduces the risk of disease..
05/12/202315:00GLOBERoche announces positive Phase III results for inavolisib..
04/12/202315:00GLOBERoche enters into a definitive merger agreement to acquire..
27/11/202315:00GLOBERoche expands hepatitis diagnostics portfolio to help..
16/11/202315:00GLOBERoche launches automated serology hepatitis E virus tests,..
14/11/202315:00GLOBERoche’s subcutaneous injection of Tecentriq recommended by..
09/11/202315:00GLOBERoche’s Elecsys NfL test, an important aid for those living..
31/10/202305:01GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche announces..
27/10/202314:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] FDA approves..
23/10/202320:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
23/10/202314:00GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche enters..
19/10/202314:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche mit gutem..
18/10/202314:03GLOBERoche IL-6 is the first immunoassay approved to aid sepsis..
18/10/202314:00GLOBERoche’s Alecensa reduces the risk of disease recurrence or..
13/10/202322:30GLOBELate-breaking data for Roche’s BTK inhibitor fenebrutinib..
12/10/202314:00GLOBENew data for Roche’s OCREVUS show that after 10 years of..
11/10/202315:00GLOBERoche’s OCREVUS twice-yearly, 10-minute subcutaneous..
10/10/202314:00GLOBERoche’s Vabysmo maintained vision improvements with extended..
04/10/202314:00GLOBEMajority of newborn babies with spinal muscular atrophy..
02/10/202314:00GLOBERoche to present new key clinical and real-world data at..
07/09/202320:00GLOBERoche and Alnylam report positive topline results from Phase..
01/09/202314:00GLOBERoche’s Alecensa delivers unprecedented Phase III results..
29/08/202318:00GLOBERoche’s Tecentriq becomes the first subcutaneous..
29/08/202314:00GLOBEEuropean Commission approves Roche’s Evrysdi for babies..
23/08/202314:22GLOBE[Ad hoc announcement pursuant to Art. 53 LR] Roche provides..
27/07/202314:00GLOBE[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche verzeichnet..

최근 히스토리

Delayed Upgrade Clock